Patients as Partners US Relaunches Virtually and Globally

Share Article

The Conference Forum is pleased to announce the relaunch of the 7th annual Patients as Partners US conference in a live virtual format on August 19-21, 2020.

Patients as Partners US

“Relaunching on a virtual platform allows for more involvement from patients, biopharma, advocacy, academia and other stakeholders globally to demonstrate how patient engagement gets done,” Kate Woda, Conference Director, Patients as Partners US

The Conference Forum is pleased to announce the relaunch of the 7th annual Patients as Partners US conference in a live virtual format on August 19-21, 2020.

Patients as Partners US is the first conference in the US guided by patients with Pharma R&D executives and FDA to demonstrate how patient involvement gets implemented throughout the medicines development cycle in order to drive greater efficiencies in getting therapeutics to patients faster.

The event is co-chaired by Jamie Troil Goldfarb, a cancer veteran and advocate; Marilyn Metcalf, PhD, Senior Director, Patient Engagement, GSK; and Pablo Graiver, VP, Patient Engagement Digital Strategy, IQVIA.

It features representation from three FDA agencies, who will provide patient engagement guidance updates and new efforts: Anindita Saha, Director of External Expertise and Partnerships (EEP), CDRH; Captain Robyn Bent, Patient Focused Drug Program Director, CDER, FDA; and Karen Jackler, Patient Engagement Program Manager, CDER.

“Relaunching on a virtual platform allows for more involvement from patients, biopharma, advocacy, academia and other stakeholders globally to demonstrate how patient engagement gets done,” said Kate Woda, the Patients as Partners US conference director. The virtual format expands the program over three, shorter and more manageable days that allow for more discussion and engagement opportunities.

Keynote Speakers will be addressing the following topics:

Joanne Waldstreicher, MD, CMO, Johnson & Johnson will provide her perspective, as Johnson & Johnson's Chief Medical Officer, on Making the Patient Experience Central to Business Strategy and Purpose.

Jeff Borghoff, Alzheimer’s Patient Advocate, will provide Insights into His Experience in the Biogen/Eisai Alzheimer’s Trial.

Ronnie Sharpe, Cystic Fibrosis Advocate, will be providing Clinical Trial Experiences as a CF Patient and Insights on Trial Disruptions from COVID-19.

Darryl Sleep, MD, SVP, Global Medical and CMO, Amgen will offer a CMO's Perspective on Patient-Centric Research & Building a Culture of Patient Centricity.

Barry Greene, President, Alnylam Pharmaceuticals, will speak about Partnering with Advocacy to Help Patients with Clinical Trial Enrollment, Disease Education and Access to Treatments.

Ken Getz, MBA, Director and Associate Professor / Founder and Board Chair, Tufts CSDD/CISCRP, will offer New Data on Patient Preferences and Experiences to Inform Patient Engagement Strategies and Tactics.

Cornerstone speaker, Leah Fine, Senior Director, Excellence in Screening and Care, GO2 Foundation for Lung Cancer, will provide an Update on the Centers of Excellence Program and Integrating Data into Annual Strategy in a GO2 Foundation Case Study.

Chip Bell, PhD, Customer Service Guru, will deliver tangible examples of What We Can Learn From the Service Industry To Bring Value Back to Patients.

“This has been a time of challenge for patients and care partners, patient organizations, industry, regulators, and our greater society around the world. It is more important than ever to come together to create greater efficiencies and achieve better clinical outcomes for all patients,” said Dr Metcalf, co-chair of the conference.

Additional topics covered include biopharma strategies for applying patient engagement initiatives and demonstrating impact; strategies for increased inclusion of racial and ethnic minorities in clinical trials; progress on patient data ownership; and the next milestones and actions for direct-to-patient clinical trials.

About Patients as Partners US:
Patients as Partners US was established in 2013 as the first conference to demonstrate how patient involvement gets implemented throughout the medicines development life-cycle in order to drive greater efficiencies in getting therapeutics to patients faster.

It is co-produced with patients, industry, academia, government and nonprofit organizations to address the needs of all stakeholders seeking to implement and advance patient involvement across the entire clinical development continuum.

To learn more about the event, please visit PatientsasPartners.org

About the Conference Forum:
The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused.

The Conference Forum presents strategic level conferences, both public and private, as well as developing focus groups and advisory boards for professionals in the life science and healthcare industries. They currently offer conferences for pharma/biotech professionals including R&D leaders, CEOs, business development/licensing, medical affairs/safety, chief patient officers/advocates, clinical innovation champions, investors and drug delivery specialists. The company also publishes six newsletters, reports and produces podcasts.

Learn more about The Conference Forum at theconferenceforum.org.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

BreAnna Bugbee
Visit website